Ruxolitinib (INCB018424) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3.
| Quantity | 500 mg, 1 gram |
|---|
Be the first to review “Ruxolitinib”
Related products
Powder for Hairloss Treatment Research
$500.00
Sale!
Powder for Hairloss Treatment Research
Price range: $150.00 through $1,000.00
Sale!
Powder for Hairloss Treatment Research
Price range: $165.00 through $255.00
Sale!
Powder for Hairloss Treatment Research
Price range: $120.00 through $1,800.00
Sale!
Powder for Hairloss Treatment Research
Price range: $355.00 through $1,980.00
Sale!
Powder for Hairloss Treatment Research
Price range: $100.00 through $550.00
RU58841
Price range: $79.00 through $265.00
Sale!
Powder for Hairloss Treatment Research
Price range: $100.00 through $1,000.00
Reviews
There are no reviews yet.